Induction of macrophagic and granulocytic differentiation of murine bone marrow progenitor cells by 1,25-dihydroxyvitamin D3
- 1 September 1993
- journal article
- laboratory investigations
- Published by Springer Nature in Calcified Tissue International
- Vol. 53 (3) , 193-200
- https://doi.org/10.1007/bf01321837
Abstract
Summary 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) was recently shown to promote maturation of 5-fluorouracil (5FU)-treated bone marrow cells by up-regulating macrophage-colony stimulating factor (M-CSF) receptors in the presence of interleukin la (IL-1α). In order to reveal how 1,25(OH)2D3 interacts with colony-stimulating factors and regulates the differentiation of bone marrow progenitor cell populations, in the present study, natural bone marrow cells were isolated from untreated mice and used in a-minimum essential medium supplemented with 20% heat-inactivated horse serum without added appropriate cytokines. Under the conditions, cells spontaneously differentiated gradually with days of culture, as assessed by expression of macrophage differentiation antigens such as Mac-1 (CD11b) and F4/80. Both M-CSF and granulocyte macrophage-colony stimulating factor (GM-CSF) induced only Mac-1 antigen expression. Simultaneous treatment with M-CSF and 1,25(OH)2D3 enhanced the M-CSF's effect on expression of both antigens, although (1,25(OH)2D3) per se has no effect on the expression for up to 11 days. In addition, successive treatment with 1,25(OH)2D3 and M-CSF or GM-CSF dramatically enhanced expression of both antigens or Mac-1 antigen, respectively. Similarly, both simultaneous and successive treatment with 1,25(OH)2D3 and M-CSF significantly enhanced phagocytic activity and H2O2 production, whereas successive treatment with (1,25(OH)2D3) and GM-CSF significantly enhanced only phagocytic activity. Enzymehistochemical study demonstrated that cells treated simultaneously or successively with 1,25(OH)2D3 and M-CSF were strongly positive for nonspecific esterase (NSE), a macrophage-specific marker, and that simultaneous or successive treatment with 1,25(OH)2D3 and GM-CSF yielded cells strongly positive for NSE or for chloroacetate esterase (ChAE), a granulocyte-specific marker, respectively. These findings suggest that 1,25(OH)2D3 primes bone marrow progenitor cell populations not only to M-CSF but also to GM-CSF and thereby accelerates the CSFs-dependent differentiation of the cells to the macrophage or granulocyte.Keywords
This publication has 31 references indexed in Scilit:
- Phorbol ester-like action of staurosporine on the cAMP response to prostaglandin E2 in two macrophage-like cell lines at distinct differentiation stagesCellular Signalling, 1992
- Control of Granulocytes and Macrophages: Molecular, Cellular, and Clinical AspectsScience, 1991
- Establishment of murine macrophage-like mutant and hybrid cell lines: Comparative analysis of the differentiation induced by 1α,25-dihydroxyvitamin D3 and recombinant murine interferon-γCellular Immunology, 1991
- Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage HematopoietinScience, 1985
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984
- Differential Modulation of Macrophage Membrane Markers by Interferon: Analysis of Fc and C3b Receptors, Mac-1 and Ia Antigen ExpressionJournal of Interferon Research, 1983
- 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochemical and Biophysical Research Communications, 1981
- Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture.The Journal of Experimental Medicine, 1981
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981
- Mac‐1: a macrophage differentiation antigen identified by monoclonal antibodyEuropean Journal of Immunology, 1979